Abstract: Lightweight inter-satellite handover device and method for a mega LEO satellite network are provided. An attribute extraction sub-module extracts attributes of handover users in a user information storage unit. Based on the attributes of the handover users, a cluster sub-module clusters the handover users into user clusters. A decision set generator sub-module generates target satellite sets of the user clusters, determines each target satellite of the target satellite sets of the user clusters of each LEO satellite whether belongs to LEO satellites in a management domain of a handover decision point of managing the LEO satellite based on management domain information in a LEO satellite information storage unit, and if YES, performing inter-satellite handover by a centralized decision unit, otherwise performing inter-satellite handover by a distributed decision unit.

Abstract: A cathode active material for a lithium secondary battery according to an embodiment of the present invention includes a lithium metal oxide particle containing nickel, and a coating material formed on at least a portion of a surface of the lithium metal oxide particle. The coating material includes a metalloid element or a metal element. A surface coating level of the cathode active material is 0.3 or more.

Abstract: The present invention relates to a retinal-containing multilamellar vesicle and, more specifically, to a retinal-containing multilamellar vesicle comprising 0.01-5% by weight of retinal, 0.1-10% by weight of rapeseed sterol, 0.1-10% by weight of phytosteryl/behenyl/octyldodecyl lauroyl glutamate, 0.1-8% by weight of polyglyceryl-10 oleate, 0.1-10% by weight of cholesterol, 0.01-5% by weight of hydrogenated lecithin, 0.01-5% by weight of ceramide, 1-15% by weight of squalane, 0.1-10% by weight of vegetable butter, 3-30% by weight of oily liquid, 1-20% by weight of glycerin, and 30-70% by weight of water, and to a cosmetic composition comprising same.

Abstract: The present invention relates to: a novel Lactobacillus intestinalis YT2 strain (deposition number: KCCM11812P); and a composition for preventing, alleviating, or treating menopause, comprising, as an active ingredient, Lactobacillus intestinalis comprising the novel strain. The present inventors have established an animal model for menopause through ovariectomy, confirmed changes of the distribution of intestinal microorganisms by the model, identified and isolated a novel Lactobacillus intestinalis strain among lactic acid bacteria of which the distribution is significantly reduced in the menopausal model, and confirmed effects, by means of the novel strain and previously reported Lactobacillus intestinalis strains, of alleviating menopausal symptoms, such as the inhibition of an increase in body fat, the inhibition of a decrease in bone mineral density, the inhibition of an increase in the pain sensitivity, and the alleviation of depression.

Abstract: Various embodiments are directed to techniques for ensuring that a negotiable instrument has not been altered between the time the instrument leaves the hands of the payor and when the check is presented for redemption by the payee by recording an image of the check in a data block in a blockchain and retrieving the image when the check is presented for redemption for comparison with the check. A match between the stored image and the check indicates that no alteration of the check has occurred.

Abstract: The present application relates to a novel promoter and a method for producing a desired substance using the same.

Abstract: The present invention relates to a composition for an encapsulant film, including an ethylene/alpha-olefin copolymer having excellent volume resistance and light transmittance, and an encapsulant film using the same.

Abstract: A method for etching materials in which organic solvents are added to the etching mixture and combined in a mixing arrangement. When agitated organic materials mix with the etching agent and interact with the underlying material to form a shield around the etched areas that prevents the additional interaction of water with the newly etched areas and enables the etching of silicon oxides (SiOx) but does not oxidize Si. This method leads to milder reactions with less heat generation and avoids the safety hazards associated with conventional etching methods.

Abstract: Turbine fracturing equipment is provided. The turbine fracturing equipment includes: a turbine engine, having an exhaust end configured to discharge exhaust gas; an exhaust pipe having a first end and a second end, the first end of the exhaust pipe being configured such that the exhaust gas discharged from the exhaust end of the turbine engine enters the exhaust pipe, and the second end of the exhaust pipe being configured to discharge the exhaust gas in the exhaust pipe; and an exhaust gas energy recovery device, the exhaust gas energy recovery device including a thermal energy recovery mechanism configured to recover thermal energy of the exhaust gas and a kinetic energy recovery mechanism configured to recover kinetic energy of the exhaust gas, at least a part of the thermal energy recovery mechanism and at least a part of the kinetic energy recovery mechanism are arranged in the exhaust pipe.

Abstract: A user equipment (UE) may map a demodulation reference signal (DMRS) sequence to a first symbol in a set of resource blocks (RBs) of an uplink long burst, and the first symbol may occur at the beginning of the uplink long burst. The DMRS sequence may be “front-loaded” in the uplink long burst. The DMRS sequence may be dependent upon RB locations. When the DMRS sequence is mapped to the beginning of an uplink long burst, uplink control information (UCI) may be mapped in a physical uplink shared channel (PUSCH). A UE may map UCI in a PUSCH after the DMRS sequence is mapped to the beginning of the uplink long burst. When the base station receives an uplink long burst including the front-loaded DMRS and the UCI mapped in the PUSCH, the base station may identify the DMRS for channel estimation/interference cancelation of the UCI carried on the PUSCH.

Abstract: A tunnel field effect transistor includes a constant current formation layer, a source region and a drain region provided on the constant current formation layer, a channel layer provided between the source region and the drain region, a gate electrode provided on the channel layer, and a gate insulating film provided between the gate electrode and the channel layer, wherein the source region and the drain region have different conductivity types, and the constant current formation layer forms a constant current between the drain region and the constant current formation layer.

Abstract: The present disclosure provides an image compression method, including steps of: acquiring a human-eye fixation point on an original image, and determining a fixation region and a non-fixation region of the original image according to the human-eye fixation point; and compressing the non-fixation region, and generating a compressed image according to the fixation region and the compressed non-fixation region. The present disclosure also provides an image display method, an image compression apparatus, an image display apparatus, and a computer readable medium.

Abstract: A communication device of a vehicle transmits a charging permission request message to a server and receives charging permission information from the server. A charging requester is configured to transmit a charging request message including the charging permission information to a charging device and a power receiver is configured to receive a charging response message from the charging device and to wirelessly receive power from the charging device.

Abstract: The present invention relates to new antibody-drug conjugates (ADCs) targeting DLK1, active metabolites of such ADCs, methods for preparation of such ADCs, uses for such ADCs in treatment and/or prevention of illnesses, and uses for such ADCs in production of drugs for treatment and/or prevention of diseases, more specifically, uses for such ADCs in producing drugs for treatment and/or prevention of proliferative and/or angiogenetic diseases, for example, cancer. More particularly, the present invention relates to an antibody-drug conjugate comprising an antibody binding with DLK1 or an antigen-binding fragment thereof, and a pharmaceutical composition comprising the same.

Abstract: Processes and systems for correlating well log data sets from well logging passes within a well bore. In some embodiments, a process for well log depth matching can include normalizing a first well log from a first logging pass obtained within a well bore and a second well log from a second logging pass obtained within the well bore, performing a pre-shift, performing feature picking to identify one or more features along the second well log, performing normalized cross-correlation based optimization between the first well log and the second well log to match the one or more features along the second well log to the same one or more features of the first well log and generating a shift table for depth shifting the one or more features of the second well log and the first well log.

Abstract: The present invention relates to a pet genome-based matchmaking social network system and a method for providing pet genome-based matchmaking information, the system comprising: a gene analysis device unit which provides pet gene analysis information; a bioinformatics information analysis device unit which provides information that may appear during breeding through bioinformatics analysis based on the gene analysis information; a basic information input unit which receives various information about pets from pet owners; a database unit which stores collected and analyzed information; and a pet matching recommendation unit which recommends a pet with the highest matching degree according to an application for matching.

Abstract: The present invention relates to a vibrating wearable device including a body. The body includes a first layer and a second layer, wherein a compartment is formed between the first layer and the second layer; the first layer is farther away from the wearer's body surface, but the second layer is closer to the wearer's body surface. Besides, the body includes at least one resonance frequency supply unit disposed within the second layer or inside the compartment according to an arrangement, which can partly or completely cover the body.

Abstract: Disclosed are a catalyst for an electrochemical cell and a method of manufacturing the catalyst. The catalyst includes a support, a first catalyst supported on the support, wherein the first catalyst is a catalyst for hydrogen oxidation reaction (HOR) or oxygen reduction reaction (ORR), a second catalyst supported on the first catalyst, wherein the second catalyst is a catalyst for oxygen evolution reaction (OER), and a protective layer formed on the first catalyst and the second catalyst.

Abstract: A content display method of a user terminal device including a bended touch screen divided into a main area and a sub area, includes displaying, on the main area, a first main content provided by a first application, and displaying, on the sub area, a first sub content associated with the first main content, receiving a user gesture input on the main area, and in response to receiving the user gesture, displaying, on the main area, a second main content provided by a second application, and displaying, on the sub area, a second sub content associated with the second main content.

Abstract: The present invention relates to a monoclonal antibody binding specifically to YKL-40. A high expression level of YKL-40 is associated with the proliferation and metastasis of cancer and a monoclonal antibody against YKL-40 exhibits an effect of inhibiting the proliferation and metastasis of cancer. Thus, the monoclonal antibody of the present disclosure can be advantageously used for diagnosing, preventing or treating cancer.